Hvilken er prisen på PT Tempo Scan Pacific Tbk (TSPC)

Prisen på PT Tempo Scan Pacific Tbk (TSPC) er $0.16403186

Hva er markedsverdien på PT Tempo Scan Pacific Tbk (TSPC)

Markedsverdien på PT Tempo Scan Pacific Tbk (TSPC) er $739.76M

PT Tempo Scan Pacific Tbk (TSPC) Inntjening

PT Tempo Scan Pacific Tbk, an Indonesian company headquartered in Jakarta with an international presence, operates primarily across three core business segments: pharmaceuticals, consumer products and cosmetics, and distribution services. Its activities encompass the trading of pharmaceutical and medical devices, alongside the manufacturing of diverse goods such as soaps, herbal products, powdered milk, food and beverages, and plastic packaging. The company also produces and markets a variety of consumer goods, cosmetic lines, and household items. Products are sold under an extensive portfolio of brands, including Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II. Beyond these, PT Tempo Scan Pacific Tbk offers a range of supplementary services, including property construction and leasing, warehousing and freight forwarding, advertising and promotion, research and development, and information technology and communication network systems. It also manages procurement, distribution, and marketing functions. Established in 1970, the company was formerly known as PT Scanchemie and functions as a subsidiary of PT Bogamulia Nagadi.

År	Inntekter	Endre
Ikke nok data for de angitte datoene.

År

Inntekter

Endre

Ikke nok data for de angitte datoene.

Selskap	Inntekter	Forskjell i inntekter	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN

Selskap

Inntekter

Forskjell i inntekter

Land